Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 91Stomach Neoplasms 44Pancreatic Neoplasms 37Rectal Neoplasms 29Colonic Neoplasms 23Neoplasms 22Esophageal Neoplasms 21Squamous Cell Carcinoma of Head and Neck 20Neoplasm Metastasis 18Cholangiocarcinoma 16Adenocarcinoma Of Esophagus 16Biliary Tract Neoplasms 13Parkinson Disease 4, Autosomal Dominant Lewy Body 12Head and Neck Neoplasms 12Esophageal Squamous Cell Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Adenocarcinoma 12Urinary Bladder Neoplasms 11Ovarian Neoplasms 9Gastrointestinal Neoplasms 9Carcinoma, Hepatocellular 7Endometrial Neoplasms 6Breast Neoplasms 6Gallbladder Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Peritoneal Neoplasms 4Lung Neoplasms 4Carcinoma 4Appendiceal Neoplasms 4

Interventions

pembrolizumab 6Cetuximab 5olaparib 3atezolizumab 3Injections 3fludarabine 2Trastuzumab 2Docetaxel 2Cyclophosphamide 2Bevacizumab 2zimberelimab 1zansecimab 1tocilizumab 1taxane 1spartalizumab 1somatostatin receptor 2 1ribociclib 1pralsetinib 1pertuzumab 1pegylated granulocyte colony-stimulating factor 1lenvatinib 1ipatasertib 1inavolisib 1fludarabine phosphate 1entrectinib 1encorafenib 1durvalumab 1dapagliflozin 1cemiplimab 1brigimadlin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumors × Fluorouracil × 1 year × Clear all
NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Mirati Therapeutics Inc.

Phase 2 Recruiting
170 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡